Company intelligence / Profile preview

El Dorado

Cambridge, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

El Dorado Therapeutics is a biotechnology company focused on developing next-generation gene therapies for mucosal diseases. Incubated by ElevateBio, the company leverages advanced adeno-associated virus (AAV) vector engineering and directed evolution to target mucosal tissues such as the respiratory and gastrointestinal tracts. Its platform aims to overcome the biological barriers of mucosal surfaces, enabling the localized delivery of genetic medicines to treat both genetic and acquired conditions. By utilizing ElevateBio's BaseCamp manufacturing and development resources, El Dorado is positioned to accelerate the translation of its novel viral vectors into clinical applications.

Therapeutic areas: PulmonologyGastroenterology
Modalities: Gene therapyAAV vectors
Industry: Biotech

Partnerships

ElevateBio

Beyond the preview

Go deeper on El Dorado.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on El Dorado.

Explore the full profile